Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Van Hul

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Developmental Cell|September 24, 2019
Activation of Skeletal Stem and Progenitor Cells for Bone Regeneration Is Driven by PDGFRβ SignalingAnna-Marei Böhm, Naomi Dirckx, Robert J Tower, et al.
Scientific Reports|July 1, 2025
Associations between weight gain, integrase inhibitors antiretroviral agents, and gut microbiome in people living with HIV: a cross-sectional studyJulien De Greef, Khoi Nguyen Nguyen, Matthias Van Hul, et al.
Journal of Lipid Research|August 30, 2023
Dysosmobacter welbionis effects on glucose, lipid, and energy metabolism are associated with specific bioactive lipidsEmilie Moens de Hase, Camille Petitfils, Mireille Alhouayek, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 11, 2020
Intestinal NAPE-PLD contributes to short-term regulation of food intake via gut-to-brain axisMarialetizia Rastelli, Matthias Van Hul, Romano Terrasi, et al.
Microbiome|June 29, 2021
Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coinFrancesco Suriano, Sara Vieira-Silva, Gwen Falony, et al.
Journal of Cellular and Molecular Medicine|October 27, 2020
Acetate: Friend or foe against breast tumour growth in the context of obesity?Caner Yelek, Lionel Mignion, Nicolas Joudiou, et al.
Cells|May 24, 2020
Hepatic NAPE-PLD Is a Key Regulator of Liver Lipid MetabolismCharlotte Lefort, Martin Roumain, Matthias Van Hul, et al.
Diabetologia|October 28, 2023
Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical interventionEmilie Moens de Hase, Audrey M Neyrinck, Julie Rodriguez, et al.
Journal of Cellular and Molecular Medicine|July 19, 2020
Obesity and triple-negative-breast-cancer: Is apelin a new key target?Florian Gourgue, Lionel Mignion, Matthias Van Hul, et al.
Bioactive Materials|October 20, 2023
A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatmentValentina Marotti, Yining Xu, Cécilia Bohns Michalowski, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Developmental Cell|September 24, 2019
Activation of Skeletal Stem and Progenitor Cells for Bone Regeneration Is Driven by PDGFRβ SignalingAnna-Marei Böhm, Naomi Dirckx, Robert J Tower, et al.
Scientific Reports|July 1, 2025
Associations between weight gain, integrase inhibitors antiretroviral agents, and gut microbiome in people living with HIV: a cross-sectional studyJulien De Greef, Khoi Nguyen Nguyen, Matthias Van Hul, et al.
Journal of Lipid Research|August 30, 2023
Dysosmobacter welbionis effects on glucose, lipid, and energy metabolism are associated with specific bioactive lipidsEmilie Moens de Hase, Camille Petitfils, Mireille Alhouayek, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 11, 2020
Intestinal NAPE-PLD contributes to short-term regulation of food intake via gut-to-brain axisMarialetizia Rastelli, Matthias Van Hul, Romano Terrasi, et al.
Microbiome|June 29, 2021
Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coinFrancesco Suriano, Sara Vieira-Silva, Gwen Falony, et al.
Journal of Cellular and Molecular Medicine|October 27, 2020
Acetate: Friend or foe against breast tumour growth in the context of obesity?Caner Yelek, Lionel Mignion, Nicolas Joudiou, et al.
Cells|May 24, 2020
Hepatic NAPE-PLD Is a Key Regulator of Liver Lipid MetabolismCharlotte Lefort, Martin Roumain, Matthias Van Hul, et al.
Diabetologia|October 28, 2023
Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical interventionEmilie Moens de Hase, Audrey M Neyrinck, Julie Rodriguez, et al.
Journal of Cellular and Molecular Medicine|July 19, 2020
Obesity and triple-negative-breast-cancer: Is apelin a new key target?Florian Gourgue, Lionel Mignion, Matthias Van Hul, et al.
Bioactive Materials|October 20, 2023
A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatmentValentina Marotti, Yining Xu, Cécilia Bohns Michalowski, et al.
Pageof 8